Table of Contents Author Guidelines Submit a Manuscript
Behavioural Neurology
Volume 2018, Article ID 9421098, 10 pages
https://doi.org/10.1155/2018/9421098
Review Article

REM Sleep Behavior Disorder (RBD) in Dementia with Lewy Bodies (DLB)

1Department of Neurology, Show Chwan Memorial Hospital, Changhua, Taiwan
2Department of Neurology, Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan
3Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
4Sleep Center, Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan
5Vertigo and Balance Impairment Center, Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan

Correspondence should be addressed to Dean Wu; moc.liamg@93120uygnit

Received 1 February 2018; Revised 30 March 2018; Accepted 8 April 2018; Published 19 June 2018

Academic Editor: Ying-Jui Ho

Copyright © 2018 Po-Chi Chan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Heidebrink, “Is dementia with Lewy bodies the second most common cause of dementia?” Journal of Geriatric Psychiatry and Neurology, vol. 15, no. 4, pp. 182–187, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Zaccai, C. McCracken, and C. Brayne, “A systematic review of prevalence and incidence studies of dementia with Lewy bodies,” Age and Ageing, vol. 34, no. 6, pp. 561–566, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. S. S. M. Chan, H. F. K. Chiu, L. C. W. Lam, and V. P. Y. Leung, “Prevalence of dementia with Lewy bodies in an inpatient psychogeriatric population in Hong Kong Chinese,” International Journal of Geriatric Psychiatry, vol. 17, no. 9, pp. 847–850, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Shergill, E. Mullan, P. D'ath, and C. Katona, “What is the clinical prevalence of Lewy body dementia?” International Journal of Geriatric Psychiatry, vol. 9, no. 11, pp. 907–912, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. I. G. McKeith, B. F. Boeve, D. W. Dickson et al., “Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium,” Neurology, vol. 89, no. 1, pp. 88–100, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Onofrj, A. Thomas, G. D'Andreamatteo et al., “Incidence of RBD and hallucination in patients affected by Parkinson’s disease: 8-year follow-up,” Neurological Sciences, vol. 23, no. 0, pp. s91–s94, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. I. G. McKeith, D. Galasko, K. Kosaka et al., “Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) report of the consortium on DLB international workshop,” Neurology, vol. 47, no. 5, pp. 1113–1124, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. R. B. Postuma and C. Trenkwalder, “Neurodegeneration in REM sleep behavior disorder stratification keeps improving,” Neurology, vol. 88, no. 16, pp. 1486-1487, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Heller, N. Brcina, I. Dogan et al., “Brain imaging findings in idiopathic REM sleep behavior disorder (RBD) – a systematic review on potential biomarkers for neurodegeneration,” Sleep Medicine Reviews, vol. 34, pp. 23–33, 2017. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Iranzo, H. Stockner, M. Serradell et al., “Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder,” Movement Disorders, vol. 29, no. 14, pp. 1774–1780, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. Hamilton, K. M. Landy, D. P. Salmon, L. A. Hansen, E. Masliah, and D. Galasko, “Early visuospatial deficits predict the occurrence of visual hallucinations in autopsy-confirmed dementia with Lewy bodies,” The American Journal of Geriatric Psychiatry, vol. 20, no. 9, pp. 773–781, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Iranzo, A. Fernández-Arcos, E. Tolosa et al., “Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients,” PLoS One, vol. 9, no. 2, article e89741, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Li, S. H. Li, W. Su, and H. B. Chen, “Diagnostic accuracy of REM sleep behaviour disorder screening questionnaire: a meta-analysis,” Neurological Sciences, vol. 38, no. 6, pp. 1039–1046, 2017. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Y. Uc, K. C. Doerschug, V. Magnotta et al., “Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting,” Neurology, vol. 83, no. 5, pp. 413–425, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. I. H. K. Leung, C. C. Walton, H. Hallock, S. J. G. Lewis, M. Valenzuela, and A. Lampit, “Cognitive training in Parkinson disease: a systematic review and meta-analysis,” Neurology, vol. 85, no. 21, pp. 1843–1851, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. T. J. Huh, P. A. Areán, H. Bornfeld, and A. Elite-Marcandonatou, “The effectiveness of an environmental and behavioral approach to treat behavior problems in a patient with dementia with Lewy bodies: a case study,” The Annals of Long-Term Care, vol. 16, no. 11, pp. 17–21, 2008. View at Google Scholar
  17. L. N. Gitlin, L. Winter, M. P. Dennis, N. Hodgson, and W. W. Hauck, “A biobehavioral home-based intervention and the well-being of patients with dementia and their caregivers: the COPE randomized trial,” JAMA, vol. 304, no. 9, pp. 983–991, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Tiraboschi, L. A. Hansen, M. Alford et al., “Cholinergic dysfunction in diseases with Lewy bodies,” Neurology, vol. 54, no. 2, pp. 407–411, 2000. View at Publisher · View at Google Scholar
  19. H. F. Wang, J. T. Yu, S. W. Tang et al., “Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 86, no. 2, pp. 135–143, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Stinton, I. McKeith, J. P. Taylor et al., “Pharmacological management of Lewy body dementia: a systematic review and meta-analysis,” The American Journal of Psychiatry, vol. 172, no. 8, pp. 731–742, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Dalfó, J. L. Albasanz, M. Martin, and I. Ferrer, “Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular α-synuclein/phospholipase C (PLCβ1) interactions,” Brain Pathology, vol. 14, no. 4, pp. 388–398, 2004. View at Publisher · View at Google Scholar
  22. M. S. Starr, “Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson' disease,” Synapse, vol. 19, no. 4, pp. 264–293, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. I. McKeith, T. del Ser, P. F. Spano et al., “Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study,” The Lancet, vol. 356, no. 9247, pp. 2031–2036, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. I. McKeith, A. Fairbairn, R. Perry, P. Thompson, and E. Perry, “Neuroleptic sensitivity in patients with senile dementia of Lewy body type,” BMJ, vol. 305, no. 6855, pp. 673–678, 1992. View at Publisher · View at Google Scholar
  25. D. T. Maust, H. M. Kim, L. S. Seyfried et al., “Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm,” JAMA Psychiatry, vol. 72, no. 5, pp. 438–445, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Almeida, B. Ahmed, R. Walz et al., “Depressive symptoms are frequent in atypical parkinsonian disorders,” Movement Disorders Clinical Practice, vol. 4, no. 2, pp. 191–197, 2017. View at Publisher · View at Google Scholar
  27. A. Gatt, A. Ekonomou, A. Somani et al., “Importance of proactive treatment of depression in Lewy body dementias: the impact on hippocampal neurogenesis and cognition in a post-mortem study,” Dementia and Geriatric Cognitive Disorders, vol. 44, no. 5-6, pp. 283–293, 2018. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Molloy, I. McKeith, J. T. O'Brien, and D. J. Burn, “The role of levodopa in the management of dementia with Lewy bodies,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 76, no. 9, pp. 1200–1203, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. S. B. Bonelli, G. Ransmayr, M. Steffelbauer, T. Lukas, C. Lampl, and M. Deibl, “L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia,” Neurology, vol. 63, no. 2, pp. 376–378, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. J. G. Goldman, C. G. Goetz, M. Brandabur, M. Sanfilippo, and G. T. Stebbins, “Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies,” Movement Disorders, vol. 23, no. 15, pp. 2248–2250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Prado, P. Paholpak, M. Ngo et al., “Agitation and psychosis associated with dementia with Lewy bodies exacerbated by modafinil use,” American Journal of Alzheimer's Disease & Other Dementias, vol. 27, no. 7, pp. 468–473, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. M. I. Lapid, K. M. Kuntz, S. S. Mason et al., “Efficacy, safety, and tolerability of armodafinil therapy for hypersomnia associated with dementia with Lewy bodies: a pilot study,” Dementia and Geriatric Cognitive Disorders, vol. 43, no. 5-6, pp. 269–280, 2017. View at Publisher · View at Google Scholar · View at Scopus
  33. P. R. Howard, “Sleep Disorders Classification Committee, Association of Sleep Disorders Centers,” Sleep, vol. 2, no. 1, pp. 1–137, 1979. View at Publisher · View at Google Scholar
  34. M. J. Sateia, “International Classification of Sleep Disorders-Third Edition,” Chest Journal, vol. 146, no. 5, pp. 1387–1394, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. C. H. Schenck, S. R. Bundlie, M. G. Ettinger, and M. W. Mahowald, “Chronic behavioral disorders of human REM sleep: a new category of parasomnia,” Sleep, vol. 9, no. 2, pp. 293–308, 1986. View at Publisher · View at Google Scholar · View at Scopus
  36. T. J. Ferman, B. F. Boeve, G. E. Smith et al., “Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies,” Neurology, vol. 77, no. 9, pp. 875–882, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. R. B. Postuma, J. F. Gagnon, M. Vendette, M. L. Fantini, J. Massicotte-Marquez, and J. Montplaisir, “Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder,” Neurology, vol. 72, no. 15, pp. 1296–1300, 2009. View at Publisher · View at Google Scholar
  38. M. Uchiyama, K. Tanaka, K. Isse, and M. Okawa, “Lewy body disease in a patient with REM sleep disorder,” Neurology, vol. 46, no. 5, p. 1493, 1996. View at Publisher · View at Google Scholar
  39. B. F. Boeve, M. H. Silber, C. B. Saper et al., “Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease,” Brain, vol. 130, no. 11, pp. 2770–2788, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. C. H. Schenck, B. F. Boeve, and M. W. Mahowald, “Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series,” Sleep Medicine, vol. 14, no. 8, pp. 744–748, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. S. M. Boesch, B. Frauscher, E. Brandauer, G. K. Wenning, B. Högl, and W. Poewe, “Disturbance of rapid eye movement sleep in spinocerebellar ataxia type 2,” Movement Disorders, vol. 21, no. 10, pp. 1751–1754, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Iranzo, J. Santamaria, and E. Tolosa, “The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases,” Sleep Medicine Reviews, vol. 13, no. 6, pp. 385–401, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. M. J. Gómez-Choco, A. Iranzo, Y. Blanco, F. Graus, J. Santamaria, and A. Saiz, “Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis,” Multiple Sclerosis Journal, vol. 13, no. 6, pp. 805–808, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. Z. Xi and W. Luning, “REM sleep behavior disorder in a patient with pontine stroke,” Sleep Medicine, vol. 10, no. 1, pp. 143–146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. J. M. Parish, “Violent dreaming and antidepressant drugs: or how paroxetine made me dream that I was fighting Saddam Hussein,” Journal of Clinical Sleep Medicine, vol. 3, no. 5, pp. 529–531, 2007. View at Google Scholar
  46. C. H. Schenck, M. W. Mahowald, S. W. Kim, K. A. O'Connor, and T. D. Hurwitz, “Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder,” Sleep, vol. 15, no. 3, pp. 226–235, 1992. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Schutte, “REM sleep behavior disorder seen with venlafaxine (Effexor),” Sleep Research, vol. 25, p. 364, 1996. View at Google Scholar
  48. A. Iranzo and J. Santamaria, “Bisoprolol-induced rapid eye movement sleep behavior disorder,” The American Journal of Medicine, vol. 107, no. 4, pp. 390–392, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Silber, “REM sleep behavior disorder associated with barbiturate withdrawal,” Sleep Research, vol. 25, p. 371, 1996. View at Google Scholar
  50. R. B. Postuma, “REM sleep behavior disorder,” in Oxford Textbook of Sleep Disorders, p. 375, Oxford University Press, 2017. View at Publisher · View at Google Scholar
  51. C. H. Schenck and M. W. Mahowald, “REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP,” Sleep, vol. 25, no. 2, pp. 120–138, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. C. H. Schenck, S. R. Bundlie, A. L. Patterson, and M. W. Mahowald, “Rapid eye movement sleep behavior disorder: a treatable parasomnia affecting older adults,” JAMA, vol. 257, no. 13, pp. 1786–1789, 1987. View at Publisher · View at Google Scholar · View at Scopus
  53. A. D’Agostino, R. Manni, I. Limosani, M. Terzaghi, S. Cavallotti, and S. Scarone, “Challenging the myth of REM sleep behavior disorder: no evidence of heightened aggressiveness in dreams,” Sleep Medicine, vol. 13, no. 6, pp. 714–719, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. T. Sasai, Y. Inoue, and M. Matsuura, “Do patients with rapid eye movement sleep behavior disorder have a disease-specific personality?” Parkinsonism & Related Disorders, vol. 18, no. 5, pp. 616–618, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. C. H. Schenck, T. D. Hurwitz, and M. W. Mahowald, “REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature,” Journal of Sleep Research, vol. 2, no. 4, pp. 224–231, 1993. View at Publisher · View at Google Scholar · View at Scopus
  56. E. J. Olson, B. F. Boeve, and M. H. Silber, “Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases,” Brain, vol. 123, no. 2, pp. 331–339, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. E. Sforza, J. Krieger, and C. Petiau, “REM sleep behavior disorder: clinical and physiopathological findings,” Sleep Medicine Reviews, vol. 1, no. 1, pp. 57–69, 1997. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. K. Wing, S. P. Lam, S. X. Li et al., “REM sleep behaviour disorder in Hong Kong Chinese: clinical outcome and gender comparison,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 79, no. 12, pp. 1415-1416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. S. M. Fereshtehnejad, J. Y. Montplaisir, A. Pelletier, J. F. Gagnon, D. Berg, and R. B. Postuma, “Validation of the MDS research criteria for prodromal Parkinson’s disease: longitudinal assessment in a REM sleep behavior disorder (RBD) cohort,” Movement Disorders, vol. 32, no. 6, pp. 865–873, 2017. View at Publisher · View at Google Scholar · View at Scopus
  60. R. B. Postuma, A. Iranzo, B. Hogl et al., “Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study,” Annals of Neurology, vol. 77, no. 5, pp. 830–839, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. E. J. Slow, R. B. Postuma, and A. E. Lang, “Implications of nocturnal symptoms towards the early diagnosis of Parkinson’s disease,” Journal of Neural Transmission, vol. 121, Supplement 1, pp. 49–57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. M. W. Mahowald, C. H. Schenck, and M. A. Cramer Bornemann, “Pathophysiologic mechanisms in REM sleep behavior disorder,” Current Neurology and Neuroscience Reports, vol. 7, no. 2, pp. 167–172, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. C. H. Schenck, S. R. Bundlie, and M. W. Mahowald, “Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder,” Neurology, vol. 46, no. 2, pp. 388–393, 1996. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Schenck, “REM behavior disorder (RBD) : delayed emergence of parkinsonism and/or dementia in 65% of older men initially diagnosed with idiopathic RBD, and an analysis of the minimum & maximum tonic and/or phasic electromyographic abnormalities found during REM sleep,” Sleep, vol. 26, article A316, 2003. View at Google Scholar
  65. A. Iranzo, E. Tolosa, E. Gelpi et al., “Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study,” The Lancet Neurology, vol. 12, no. 5, pp. 443–453, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Iranzo, J. Santamaria, and E. Tolosa, “Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions,” The Lancet Neurology, vol. 15, no. 4, pp. 405–419, 2016. View at Publisher · View at Google Scholar · View at Scopus
  67. Y. K. Wing, S. X. Li, V. Mok et al., “Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 83, no. 4, pp. 470–472, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. B. P. Boot, B. F. Boeve, R. O. Roberts et al., “Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study,” Annals of Neurology, vol. 71, no. 1, pp. 49–56, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. B. F. Boeve, M. H. Silber, T. J. Ferman, J. A. Lucas, and J. E. Parisi, “Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy,” Movement Disorders, vol. 16, no. 4, pp. 622–630, 2001. View at Publisher · View at Google Scholar · View at Scopus
  70. M. D. Gjerstad, B. Boeve, T. Wentzel-Larsen, D. Aarsland, and J. P. Larsen, “Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson’s disease over time,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 79, no. 4, pp. 387–391, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. J.-F. Gagnon, M. A. Bedard, M. L. Fantini et al., “REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease,” Neurology, vol. 59, no. 4, pp. 585–589, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Chiu, Y. K. Wing, L. C. Lam et al., “Sleep-related injury in the elderly—an epidemiological study in Hong Kong,” Sleep, vol. 23, no. 4, pp. 513–517, 2000. View at Publisher · View at Google Scholar
  73. C. Idzikowski, “An essay on sleep-related sexual behaviours and offences related to sexual behaviours,” in Sleep and Its Disorders Affect Society, pp. 51–76, InTech, 2014. View at Publisher · View at Google Scholar
  74. M. Ansari, F. Rahmani, M. Dolatshahi, A. Pooyan, and M. H. Aarabi, “Brain pathway differences between Parkinson’s disease patients with and without REM sleep behavior disorder,” Sleep and Breathing, vol. 21, no. 1, pp. 155–161, 2017. View at Publisher · View at Google Scholar · View at Scopus
  75. B. F. Boeve, M. H. Silber, T. J. Ferman et al., “Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder,” Sleep Medicine, vol. 14, no. 8, pp. 754–762, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Uchiyama, K. Isse, K. Tanaka et al., “Incidental Lewy body disease in a patient with REM sleep behavior disorder,” Neurology, vol. 45, no. 4, pp. 709–712, 1995. View at Publisher · View at Google Scholar · View at Scopus
  77. B. F. Boeve, D. W. Dickson, E. J. Olson et al., “Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease,” Sleep Medicine, vol. 8, no. 1, pp. 60–64, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. D. Vilas, A. Iranzo, E. Tolosa et al. et al., “Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study,” The Lancet Neurology, vol. 15, no. 7, pp. 708–718, 2016. View at Publisher · View at Google Scholar · View at Scopus
  79. F. S. Sprenger, N. Stefanova, E. Gelpi et al., “Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder,” Neurology, vol. 85, no. 20, pp. 1761–1768, 2015. View at Publisher · View at Google Scholar · View at Scopus
  80. Y. Dauvilliers, P. Jennum, and G. Plazzi, “Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy,” Sleep Medicine, vol. 14, no. 8, pp. 775–781, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. J. W. Winkelman and L. James, “Serotonergic antidepressants are associated with REM sleep without atonia,” Sleep, vol. 27, no. 2, pp. 317–321, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. R. N. Aurora, R. S. Zak, R. K. Maganti et al., “Best practice guide for the treatment of REM sleep behavior disorder (RBD),” Journal of Clinical Sleep Medicine, vol. 6, no. 1, pp. 85–95, 2010. View at Google Scholar
  83. C. L. Comella, T. M. Nardine, N. J. Diederich, and G. T. Stebbins, “Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson’s disease,” Neurology, vol. 51, no. 2, pp. 526–529, 1998. View at Publisher · View at Google Scholar · View at Scopus
  84. H. Shinno, M. Kamei, Y. Inami, J. Horiguchi, and Y. Nakamura, “Successful treatment with Yi-Gan San for rapid eye movement sleep behavior disorder,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 32, no. 7, pp. 1749–1751, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. C. H. Schenck, J. Y. Montplaisir, B. Frauscher et al., “Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group,” Sleep Medicine, vol. 14, no. 8, pp. 795–806, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. M. L. Fantini, J. F. Gagnon, D. Filipini, and J. Montplaisir, “The effects of pramipexole in REM sleep behavior disorder,” Neurology, vol. 61, no. 10, pp. 1418–1420, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. J. M. Ringman and J. H. Simmons, “Treatment of REM sleep behavior disorder with donepezil: a report of three cases,” Neurology, vol. 55, no. 6, pp. 870-871, 2000. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Bonakis, R. S. Howard, I. O. Ebrahim, S. Merritt, and A. Williams, “REM sleep behaviour disorder (RBD) and its associations in young patients,” Sleep Medicine, vol. 10, no. 6, pp. 641–645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. K. N. Anderson and J. M. Shneerson, “Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam,” Journal of Clinical Sleep Medicine, vol. 5, no. 3, pp. 235–239, 2009. View at Google Scholar
  90. M. J. Howell, P. A. Arneson, and C. H. Schenck, “A novel therapy for REM sleep behavior disorder (RBD),” Journal of Clinical Sleep Medicine, vol. 7, no. 6, pp. 639–644A, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. J. M. Shneerson, “Successful treatment of REM sleep behavior disorder with sodium oxybate,” Clinical Neuropharmacology, vol. 32, no. 3, pp. 158-159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. B. Y. Mileykovskiy, L. I. Kiyashchenko, and J. M. Siegel, “Behavioral correlates of activity in identified hypocretin/orexin neurons,” Neuron, vol. 46, no. 5, pp. 787–798, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. J. M. Siegel, “Clues to the functions of mammalian sleep,” Nature, vol. 437, no. 7063, pp. 1264–1271, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. F. Weber, S. Chung, K. T. Beier, M. Xu, L. Luo, and Y. Dan, “Control of REM sleep by ventral medulla GABAergic neurons,” Nature, vol. 526, no. 7573, pp. 435–438, 2015. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Knudsen, S. Gammeltoft, and P. J. Jennum, “Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency,” Brain, vol. 133, no. 2, pp. 568–579, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. H. Zepelin, J. M. Siegel, and I. Tobler, “Mammalian sleep,” Principles and Practice of Sleep Medicine, vol. 4, pp. 91–100, 2005. View at Google Scholar
  97. E. K. St. Louis, S. J. McCarter, B. F. Boeve et al., “Lesional REM sleep behavior disorder localizes to the dorsomedial pons,” Neurology, vol. 83, no. 20, pp. 1871–1873, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. S. J. McCarter, M. Tippmann-Peikert, D. J. Sandness et al., “Neuroimaging-evident lesional pathology associated with REM sleep behavior disorder,” Sleep Medicine, vol. 16, no. 12, pp. 1502–1510, 2015. View at Publisher · View at Google Scholar · View at Scopus
  99. H. Braak and K. Del Tredici, “Invited article: nervous system pathology in sporadic Parkinson disease,” Neurology, vol. 70, no. 20, pp. 1916–1925, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. H. Braak, E. Ghebremedhin, U. Rüb, H. Bratzke, and K. del Tredici, “Stages in the development of Parkinson’s disease-related pathology,” Cell and Tissue Research, vol. 318, no. 1, pp. 121–134, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Jouvet and F. Delorme, “Locus coeruleus et sommeil paradoxal,” Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, vol. 159, no. 4, p. 895, 1965. View at Google Scholar
  102. P. J.-P. Sastre and M. Jouvet, “Le comportement onirique du chat,” Physiology & Behavior, vol. 22, no. 5, pp. 979–989, 1979. View at Publisher · View at Google Scholar · View at Scopus
  103. T. Harada, A. Tanoue, and H. Takeuchi, “Epidemiological studies on dreams, sleep habits and mental symptoms in students aged 18–25 years and the 24 hour a day commercialization of Japanese society (1),” Sleep and Biological Rhythms, vol. 4, no. 3, pp. 274–281, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Hendricks, A. Lager, D. O'Brien, and A. R. Morrison, “Movement disorders during sleep in cats and dogs,” Journal of the American Veterinary Medical Association, vol. 194, no. 5, pp. 686–689, 1989. View at Google Scholar
  105. R. B. Postuma, J. F. Gagnon, M. Tuineaig et al., “Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal?” Sleep, vol. 36, no. 11, pp. 1579–1585, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. S. Valencia Garcia, P.-A. Libourel, M. Lazarus, D. Grassi, P.-H. Luppi, P. Fort et al., “Genetic inactivation of glutamate neurons in the rat sublaterodorsal tegmental nucleus recapitulates REM sleep behaviour disorder,” Brain, vol. 140, no. 2, pp. 414–428, 2017. View at Publisher · View at Google Scholar · View at Scopus
  107. L. T. Grinberg, U. Rueb, A. T. L. Alho, and H. Heinsen, “Brainstem pathology and non-motor symptoms in PD,” Journal of the Neurological Sciences, vol. 289, no. 1-2, pp. 81–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. H. Braak, K. D. Tredici, U. Rüb, R. A. I. de Vos, E. N. H. Jansen Steur, and E. Braak, “Staging of brain pathology related to sporadic Parkinson’s disease,” Neurobiology of Aging, vol. 24, no. 2, pp. 197–211, 2003. View at Publisher · View at Google Scholar · View at Scopus
  109. A. M. Schmeichel, L. C. Buchhalter, P. A. Low et al., “Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy,” Neurology, vol. 70, no. 5, pp. 368–373, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. G. Thomas, C. H. Adler, L. F. Lue et al., “Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction,” Acta Neuropathologica, vol. 117, no. 6, pp. 613–634, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. R. Frigerio, H. Fujishiro, T. B. Ahn et al., “Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?” Neurobiology of Aging, vol. 32, no. 5, pp. 857–863, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. B. N. Dugger, B. F. Boeve, M. E. Murray et al., “Rapid eye movement sleep behavior disorder and subtypes in autopsy-confirmed dementia with Lewy bodies,” Movement Disorders, vol. 27, no. 1, pp. 72–78, 2012. View at Publisher · View at Google Scholar · View at Scopus
  113. C. H. Schenck, E. Garcia-Rill, R. D. Skinner, M. L. Anderson, and M. W. Mahowald, “A case of REM sleep behavior disorder with autopsy-confirmed Alzheimer’s disease: postmortem brain stem histochemical analyses,” Biological Psychiatry, vol. 40, no. 5, pp. 422–5, 1996. View at Publisher · View at Google Scholar · View at Scopus
  114. Y. Chiba, E. Iseki, H. Fujishiro et al., “Primary visual cortical metabolism and rapid eye movement sleep behavior disorder in dementia with Lewy bodies,” Psychiatry and Clinical Neurosciences, vol. 68, no. 2, pp. 137–144, 2014. View at Publisher · View at Google Scholar · View at Scopus
  115. M. E. Murray, T. J. Ferman, B. F. Boeve et al., “MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies,” Neurology, vol. 81, no. 19, pp. 1681–1689, 2013. View at Publisher · View at Google Scholar · View at Scopus
  116. K. Kasanuki, T. J. Ferman, M. E. Murray et al., “Daytime sleepiness in dementia with Lewy bodies is associated with neuronal depletion of the nucleus basalis of Meynert,” Parkinsonism & Related Disorders, vol. 50, pp. 99–103, 2018. View at Publisher · View at Google Scholar · View at Scopus
  117. R. S. Turner, C. J. D'Amato, R. D. Chervin, and M. Blaivas, “The pathology of REM sleep behavior disorder with comorbid Lewy body dementia,” Neurology, vol. 55, no. 11, pp. 1730–1732, 2000. View at Publisher · View at Google Scholar · View at Scopus
  118. Y. Y. Lai, K. C. Hsieh, D. Nguyen, J. Peever, and J. M. Siegel, “Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: an animal model of motor disorders in sleep,” Neuroscience, vol. 154, no. 2, pp. 431–443, 2008. View at Publisher · View at Google Scholar · View at Scopus
  119. M. Emre, D. Aarsland, R. Brown et al., “Clinical diagnostic criteria for dementia associated with Parkinson’s disease,” Movement Disorders, vol. 22, no. 12, pp. 1689–1707, 2007. View at Publisher · View at Google Scholar · View at Scopus
  120. B. N. Dugger, M. E. Murray, B. F. Boeve et al., “Neuropathological analysis of brainstem cholinergic and catecholaminergic nuclei in relation to rapid eye movement (REM) sleep behaviour disorder,” Neuropathology and Applied Neurobiology, vol. 38, no. 2, pp. 142–152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  121. I. G. McKeith, D. W. Dickson, J. Lowe et al., “Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium,” Neurology, vol. 65, no. 12, pp. 1863–1872, 2005. View at Publisher · View at Google Scholar · View at Scopus